Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2022-03-02 11:54 am Sale | 2022-02-28 | 13G | PACIRA BIOSCIENCES INC PCRX | BAILLIE GIFFORD & CO | 2,170,707 4.840% | -184,533 (-7.83%) | Filing History |
| 2022-02-14 10:05 am Purchase | 2021-12-31 | 13G | PACIRA BIOSCIENCES INC PCRX | MACQUARIE GROUP LTD | 4,205,522 9.440% | 1,452,880 (+52.78%) | Filing History |
| 2022-02-10 5:22 pm Sale | 2021-12-31 | 13G | PACIRA BIOSCIENCES INC PCRX | Renaissance Technologies LLC | 1,849,197 4.150% | -775,862 (-29.56%) | Filing History |
| 2022-02-10 08:32 am Purchase | 2021-12-31 | 13G | PACIRA BIOSCIENCES INC PCRX | VANGUARD GROUP INC | 4,665,955 10.470% | 298,689 (+6.84%) | Filing History |
| 2022-01-27 5:13 pm Unchanged | 2021-12-31 | 13G | PACIRA BIOSCIENCES INC PCRX | BlackRock, Inc. BLK | 6,821,518 15.300% | 0 (Unchanged) | Filing History |
| 2022-01-27 09:49 am Purchase | 2021-12-31 | 13G | PACIRA BIOSCIENCES INC PCRX | BAILLIE GIFFORD & CO | 2,355,240 5.290% | 2,355,240 (New Position) | Filing History |
| 2022-01-26 09:16 am Sale | 2021-12-31 | 13G | PACIRA BIOSCIENCES INC PCRX | BlackRock, Inc. BLK | 6,821,518 15.300% | -278,329 (-3.92%) | Filing History |